Status:
UNKNOWN
Comparative Analysis in Detection of Atrial Arrhythmia and ECG Quality in Three Different Insertable Cardiac Monitors
Lead Sponsor:
Kansas City Heart Rhythm Research Foundation
Conditions:
Arrhythmias, Cardiac
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Comparative analysis of available ILR devices models Abbot Confirm RxTM, Medtronic Reveal LINQTM, and Biotronik BIOMONITOR., evaluating detection performance and effective of transmission of these dev...
Detailed Description
All devices have different algorithms for arrhythmia detection and structural design. Consequently, these devices vary in sensitivity of arrhythmia detection and data transmission.Therefore, we aim to...
Eligibility Criteria
Inclusion
- Patients \> 18 years of age with appropriate indication for ILR for atrial arrhythmia management.
Exclusion
- Inability to give consent
Key Trial Info
Start Date :
September 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04471584
Start Date
September 21 2020
End Date
March 1 2022
Last Update
September 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kansas City Heart Rhythm Institute
Overland Park, Kansas, United States, 66211